[1]
G. Furneri, C. Marchesi, and L. Santoni, “[Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]”, FE, vol. 17, no. 1, pp. 29–39, Mar. 2016.